In order to promote the long-term sustainability of the EPO, a budget-neutral fee policy reform has been implemented, which includes…
The first scientific and practical conference organized by the Assembly of Eurasian Patent Attorneys (AEPA) and dedicated to the 30th…
The European Patent Office (EPO) and National Institute of Industrial Property of Chile (INAPI) have signed a Memorandum of Understanding…
On June 4, 2024, the Supreme Court of Russia ruled in favor of AstraZeneca (patentee) against KRKA (opponent) regarding the…
Representatives of Patentica, Denis Yachmenenko, Kseniya Golyatkina and Dmitriy Stakhiy, visited the Suzhou Intellectual Property International Service Center in China…
Violations of intellectual property rights and unauthorized use of means of individualization will face harsher penalties. This proposed bill was…
The most recent collaborative report released by the European Investment Bank (EIB) and the European Patent Office (EPO) offers a…
The US Patent and Trademark Office (USPTO) recently suggested a new regulation for submitting terminal disclaimers to overcome obviousness-type double…
Partners of Patentica Maria Nilova and Elena Dmitrenko participated in the LESI 2024 Annual Conference in Madrid, held from April…
The latest enhancements made to the EPO’s popular Deep Tech Finder are enhancing its utility for investors seeking investment-ready deep…
On the 8th of February, 2024, amendments and additions were made to the order "On approval of the Rules for…
Dengue fever is a severe viral disease spread by vectors. The viruses responsible for dengue fever are known as arboviruses.…